av/acura-pharmaceuticals--big.svg

COM:ACURAPHARM

Acura Pharmaceuticals, Inc.

  • Stock

Market Cap

303.61K

Beta: -

Volume Today

3

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
net income
-13.90M
-
-13.21M
4.98%
-4.99M
62.23%
-7.39M
48.09%
-5.68M
23.09%
-3.84M
32.38%
-3.77M
1.77%
-1.21M
67.99%
-879K
27.24%
depreciation and amortization
134K
-
274K
104.48%
332K
21.17%
345K
3.92%
294K
14.78%
280K
4.76%
273K
2.50%
125K
54.21%
90K
28.00%
deferred income tax
-969K
-
447K
146.13%
740K
65.55%
237K
67.97%
47K
80.17%
-296K
729.79%
2.60M
978.72%
stock based compensation
1.22M
-
890K
26.75%
606K
31.91%
588K
2.97%
464K
21.09%
218K
53.02%
108K
50.46%
36K
66.67%
58K
61.11%
change in working capital
-1.37M
-
366K
126.68%
-563K
253.83%
510K
190.59%
268K
47.45%
-183K
168.28%
121K
166.12%
-340K
380.99%
477K
240.29%
accounts receivables
-194K
-
118K
160.82%
-69K
158.47%
19K
127.54%
23K
21.05%
44K
-
-399K
1,006.82%
469K
217.54%
inventory
-282K
-
-254K
9.93%
-302K
18.90%
-59K
80.46%
103K
274.58%
-44K
-
399K
1,006.82%
-469K
217.54%
accounts payables
-720K
-
-57K
92.08%
-107K
87.72%
-33K
69.16%
-74K
124.24%
602K
913.51%
-368K
161.13%
-206K
44.02%
161K
178.16%
other working capital
-176K
-
559K
417.61%
-85K
115.21%
583K
785.88%
216K
62.95%
-785K
463.43%
489K
162.29%
-134K
127.40%
316K
335.82%
other non cash items
1.22M
-
188K
84.53%
186K
1.06%
145K
22.04%
99K
31.72%
-85K
185.86%
53K
162.35%
668K
1,160.38%
-488K
173.05%
net cash provided by operating activities
-13.68M
-
-11.04M
19.26%
-3.69M
66.61%
-5.56M
50.84%
-4.51M
18.93%
-3.91M
13.35%
-618K
84.19%
-719K
16.34%
-742K
3.20%
investments in property plant and equipment
-23K
-
-2.13M
9,182.61%
-214K
89.98%
-75K
64.95%
acquisitions net
2M
-
purchases of investments
-7.61M
-
-2.20M
71.06%
-3.52M
59.87%
sales maturities of investments
13.89M
-
4.34M
68.78%
3.83M
11.67%
10.87M
183.89%
other investing activites
-2M
-
14K
100.70%
309K
-
net cash used for investing activites
6.25M
-
-2K
100.03%
108K
5,500%
10.80M
9,898.15%
309K
97.14%
debt repayment
-1.96M
-
-2.54M
29.59%
-2.76M
8.66%
-2.57M
6.78%
-1.38M
46.56%
-269K
80.44%
-17K
93.68%
common stock issued
1K
-
1K
0%
7.86M
786,100%
4M
-
2K
99.95%
14K
600%
3K
78.57%
3K
0%
common stock repurchased
-2
-
-8
300%
dividends paid
-269.00K
-
-8
100.00%
other financing activites
12.29M
-
-521K
104.24%
-611K
17.27%
1K
100.16%
4.35M
-
2.75M
36.78%
805K
70.73%
408.02K
49.31%
net cash used provided by financing activities
12.29M
-
-520K
104.23%
5.29M
1,117.50%
-2.54M
147.99%
1.24M
148.84%
1.78M
43.47%
1.39M
21.92%
270K
80.56%
394K
45.93%
effect of forex changes on cash
net change in cash
4.86M
-
-11.57M
337.79%
1.71M
114.79%
2.70M
57.57%
-2.96M
209.83%
-2.13M
28.10%
771K
136.21%
-449K
158.24%
-348K
22.49%
cash at beginning of period
7.48M
-
12.34M
65.06%
774K
93.73%
2.48M
221.06%
5.18M
108.49%
2.22M
57.15%
91K
95.90%
862K
847.25%
413K
52.09%
65K
84.26%
cash at end of period
12.34M
-
774K
93.73%
2.48M
221.06%
5.18M
108.49%
2.22M
57.15%
91K
95.90%
862K
847.25%
413K
52.09%
65K
84.26%
65K
0%
operating cash flow
-13.68M
-
-11.04M
19.26%
-3.69M
66.61%
-5.56M
50.84%
-4.51M
18.93%
-3.91M
13.35%
-618K
84.19%
-719K
16.34%
-742K
3.20%
capital expenditure
-23K
-
-2.13M
9,182.61%
-214K
89.98%
-75K
64.95%
free cash flow
-13.70M
-
-13.18M
3.81%
-3.90M
70.39%
-5.64M
44.49%
-4.51M
20.01%
-3.91M
13.35%
-618K
84.19%
-719K
16.34%
-742K
3.20%

All numbers in (except ratios and percentages)